(redirected from Adjuvant treatment)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Adjuvant treatment: palliative treatment
References in periodicals archive ?
Thus postoperative staging by CT scanning should be performed to exclude distant metastasis before the commencement of adjuvant treatment, and systemic therapy should be a high priority in the design of adjuvant treatment strategies.
Yet, in many cases, surgeons were unaware whether their patient was resistant to taking adjuvant therapy (56 percent of patients), understood the risks and benefits of adjuvant treatment (54 percent), or could not tolerate adjuvant treatment (52 percent).
Furthermore, there are data suggesting that higher tumour levels of VEGF are predictive of a poorer response to systemic therapy in advanced breast cancer and are also an independent predictor of overall survival in node-positive patients following adjuvant treatment [1,2].
In February 2006, Multiferon was approved in Sweden for the first-line adjuvant treatment of high-risk malignant melanoma.
The new agent is available for adjuvant treatment of early-stage breast cancer in postmenopausal women as well as primary and secondary care for patients with advanced and recurrent breast cancer.
exemestane tablets) for adjuvant treatment of postmenopausal women with
Currently approved only for metastatic breast cancer, it's expected to become a first-line treatment after surgery for women with primary breast cancer since studies presented at this year's American Society of Clinical Oncology meeting showed adding it to chemotherapy during adjuvant treatment could halve the risk of recurrence.
Our patient is important because he presented with eye metastases 4 years after the completion of the adjuvant treatment.
Another advance over the last decade is adjuvant treatment - when hormonal treatment such as tamoxifen, and/or chemotherapy are given after the operation to reduce the chance of the cancer recurring.
4 times those seen in women receiving no adjuvant treatment.
RXi is developing NeuVax, a CD8 T-cell eliciting immunotherapy, for the adjuvant treatment of low to intermediate HER2 expressing breast cancer.